United States

People: Veracyte Inc (VCYT.OQ)

VCYT.OQ on NASDAQ Stock Exchange Global Market

2:55pm EDT
Change (% chg)

$0.19 (+0.79%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Nova, Tina 

Dr. Tina Susan Nova, Ph.D. is Independent Director of the Company. She has served since October 1, 2015 as president and chief executive officer of Molecular Stethoscope, Inc., a molecular diagnostics company. From July 2014 to August 2015, Dr. Nova was senior vice president and general manager of Illumina Inc.’s oncology business unit. From March 2000 to April 2014, Dr. Nova was a director, president and chief executive officer of Genoptix, Inc., a medical laboratory she co-founded, which was purchased by Novartis Pharmaceuticals Corporation in 2011. She has also held senior positions with Nanogen, Inc., Ligand Pharmaceuticals, Inc. and Hybritech, Inc. Dr. Nova currently serves on the board of directors of Arena Pharmaceuticals, Inc. and is vice chairman of the board of directors of the Rady Pediatric Genomics and Systems Medicine Institute, which is part of Rady Children’s Hospital-San Diego. Dr. Nova received a B.S. degree in Biological Sciences from the University of California, Irvine and a Ph.D. in Biochemistry from the University of California, Riverside.

Basic Compensation

Total Annual Compensation, USD 48,811
Restricted Stock Awards, USD 10,000
Long-Term Incentive Plans, USD --
All Other, USD 38,356
Fiscal Year Total, USD 97,167

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Bonnie Anderson


Christopher Hall


Keith Kennedy


John Bishop


Fred Cohen


Karin Eastham

As Of  30 Dec 2017